Simon Weeden

8.9k total citations · 2 hit papers
19 papers, 6.4k citations indexed

About

Simon Weeden is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Simon Weeden has authored 19 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 5 papers in Oncology. Recurrent topics in Simon Weeden's work include Sarcoma Diagnosis and Treatment (7 papers), Metastasis and carcinoma case studies (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Simon Weeden is often cited by papers focused on Sarcoma Diagnosis and Treatment (7 papers), Metastasis and carcinoma case studies (7 papers) and Gastric Cancer Management and Outcomes (6 papers). Simon Weeden collaborates with scholars based in United Kingdom, Netherlands and Belgium. Simon Weeden's co-authors include David Cunningham, William Allum, Stephen Falk, M. Nicolson, F. Lofts, Ruth E. Langley, J.H. Scarffe, David B. Smith, J N Thompson and Yu Jo Chua and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Simon Weeden

19 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

2006 4.5k citations David Cunningham, William Allum et al. New England Journal of Medicine profile →
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial

1999 1.0k citations A. Cuschieri, Simon Weeden et al. British Journal of Cancer profile →

Peers

Countries citing papers authored by Simon Weeden

Since Specialization

Citations

This map shows the geographic impact of Simon Weeden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Weeden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Weeden more than expected).

Fields of papers citing papers by Simon Weeden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Weeden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Weeden. The network helps show where Simon Weeden may publish in the future.

Co-authorship network of co-authors of Simon Weeden

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Weeden. A scholar is included among the top collaborators of Simon Weeden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Weeden. Simon Weeden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup 2007 ·JNCI Journal of the National Cancer Institute ·Ian Lewis, M. Nooij, Jeremy Whelan, Matthew R. Sydes, R. J. Grimer, Pancras C.W. Hogendoorn, Muhammad Ali Memon, Simon Weeden, Barbara Uscinska, M. van Glabbeke, Anne Kirkpatrick, Esther Hauben, Alan Craft, Antonïe H.M. Taminiau	272
2	Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer breakdown → 2006 ·New England Journal of Medicine ·David Cunningham, William Allum, Sally Stenning, J N Thompson, Cornelis J.�H. van de Velde, M. Nicolson, J.H. Scarffe, F. Lofts, Stephen Falk, Timothy Iveson, David B. Smith, Ruth E. Langley, Monica Verma, Simon Weeden, Yu Jo Chua	4494
3	Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971) 2005 ·UCL Discovery (University College London) ·David Cunningham, W H Allum, SP Stenning, Simon Weeden, (unknown)	12
4	Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma 2005 ·British Journal of Cancer ·Kathy Pritchard‐Jones, Ian Spendlove, (unknown), Jeremy Whelan, Simon Weeden, Ian Lewis, J. H. Hale, (unknown), Christos Pagonis, (unknown), (unknown), Gavin Halbert, Lindy G. Durrant	42
5	Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971) 2005 ·Journal of Clinical Oncology ·David Cunningham, W H Allum, SP Stenning, Simon Weeden	86
6	Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study 2004 ·European Journal of Cancer ·M. Nooij, Jeremy Whelan, V. Bramwell, (unknown), S. R. Cannon, Pancras C.W. Hogendoorn, J Pringle, Barbara Uscinska, Simon Weeden, A. Kirkpatrick, M. van Glabbeke, Alan Craft	39
7	45 Perioperative chemotherapy in operable gastric and lower oesophageal cancer: a randomised, controlled trial of the UK NCRI upper GI clinical studies group (the MAGIC trial, ISRCTN 93793971) 2003 ·European Journal of Cancer Supplements ·David Cunningham, William Allum, Simon Weeden	36
8	Bayesian Reporting of Clinical Trials 2003 ·Simon Weeden, Laurence S. Freedman, Mahesh Parmar	2
9	693 Does increasing dose intensity in patients with operable osteosarcoma of the extremity improve outcome? A randomised controlled trial of the European Osteosarcoma Intergroup (EOI) 2003 ·European Journal of Cancer Supplements ·M. Nooij, Ian A. Lewis, J. T. Whelan, Sandra J. Casak, Muhammad Ali Memon, Pancras C.W. Hogendoorn, Simon Weeden, Barbara Uscinska, M. van Glabbeke, A. Kirkpatrick	1
10	Influence of pathological tumour variables on long-term survival in resectable gastric cancer 2002 ·British Journal of Cancer ·(unknown), A. Cuschieri, I C Talbot, Simon Weeden	37
11	Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup 2002 ·European Journal of Cancer ·Esther Hauben, Simon Weeden, J Pringle, (unknown), Pancras C.W. Hogendoorn	136
12	The effect of local recurrence on survival in resected osteosarcoma 2001 ·European Journal of Cancer ·Simon Weeden, R. J. Grimer, S. R. Cannon, A. H. M. Taminiau, Barbara Uscinska	106
13	Patient survival after D1 and D2 resections for gastric cancer: long-term results of MRC randomized surgical trial 2001 ·European Journal of Cancer ·J W L Fielding, Simon Weeden	5
14	Received Dose and Dose-Intensity of Chemotherapy and Outcome in Nonmetastatic Extremity Osteosarcoma 2000 ·Journal of Clinical Oncology ·Ian Lewis, Simon Weeden, David Machin, Dan Stark, Alan Craft, (unknown)	60
15	A phase II study of cisplatin, ifosfamide and doxorubicin in operable primary, axial skeletal and metastatic osteosarcoma 1999 ·Annals of Oncology ·P.A. Voûte, R L Souhami, M. Nooij, R. Somers, H. Cortés-Funes, Jan W. van der Eijken, J. Pringle, Pancras C.W. Hogendoorn, A. Kirkpatrick, Barbara Uscinska, M. van Glabbeke, David Machin, Simon Weeden	38
16	The analysis of a bivariate multi-state Markov transition model for rheumatoid arthritis with an incomplete disease history 1999 ·Statistics in Medicine ·Philip J. Young, Simon Weeden, John Kirwan	5
17	Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial breakdown → 1999 ·British Journal of Cancer ·(unknown), A. Cuschieri, Simon Weeden, J W L Fielding, J Bancewicz, John Craven, V Joypaul, Matthew R. Sydes, Peter Fayers	1038
18	Suggestions for the presentation of quality of life data from clinical trials 1998 ·Statistics in Medicine ·David Machin, Simon Weeden	26
19	Suggestions for the presentation of quality of life data from clinical trials 1998 ·Statistics in Medicine ·David Machin, Simon Weeden	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact